YNIOS PHARMA is a biotech start-up, aiming to develop new oral and parenteral treatments for pathologies involving cellular degeneration induced by inflammation.
The company is building up a health platform for developing treatments for acute and chronic diseases, using its proprietary ionic compounds.
> Ischemic Stroke
> Inflammatory Bowel Disease (IBD)
> Charcot-Marie-Tooth Disease (CMT1A)